Vision

AI-engineered vaccines unlocking new solutions for cancer treatment.

Vision

AI-engineered vaccines unlocking new solutions for cancer treatment.

Scientific Value Proposition

AI-Powered Precision Cancer Therapy

Vaccines are changing how we fight cancer. Designed by AI for an individual patient or a patient group, our vaccines are built to keep cancer from coming back. What makes our AI powerful is its ability to rally the immune system’s full force — activating killer T cells, helper T cells, and even B cells. Backed by rigorous research and clinical results, our AI is bringing tomorrow’s cancer treatment to patients today.

Neogenlogic's Core Leadership

  • Jung Kyoon Choi, PhD
    Jung Kyoon Choi, PhD

    CEO, Research & Development

    • Professor at KAIST
    • Ph.D. in Science, KAIST
    • Director, SCL Science-KAIST Institute of Translational Research
    • Member of the Board of Directors, Korean Cancer Association
    • Principal Investigator, Genome Institute of Singapore (former)
  • Sangchul Kim, Esq
    Sangchul Kim, Esq

    CEO, Corporate Strategy & Partnerships

    • Vice President (CSO), SCL Science
    • Head of Corporate Strategy Division, SCL
    • Completed The College of Law of England & Wales
    • Member, European Law Association
  • Pilnam Kim, PhD
    Pilnam Kim, PhD

    CSO, Scientific Strategy & Innovation

    • Professor at KAIST
    • Ph.D. in Engineering, SNU
    • Senior Research Scientist, KIST (former)
    • Postdoctoral Research Associate, Princeton University (former)
    • Postdoctoral Research Associate, MIT (former)
  • Chun-sik Yang
    Chun-sik Yang

    CFO, Financial Planning & Management

    • Vice President (COO & CFO), SCL Science
    • Head of Financial Strategy Office, SCL Holdings
    • CEO, KT Skylife (former)
    • Head of Business Planning (CFO/CSO), KT Skylife (former)